Sign in

CIK 0001761612

  • Non-accelerated filer
  • Smaller reporting company

BICYCLE THERAPEUTICS PLC

Sign in to watch
Ticker
BCYC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
United Kingdom
Entity type
Operating
Phone
+44 1223261503
Business address
BLOCKS A & B, PORTWAY BUILDING, GRANTA PARK, GREAT ABINGTON, CAMBRIDGE, United Kingdom, CB21 6GS
Former names
BICYCLE THERAPEUTICS Ltd
  1. 4 Grant or award Director acquired 5,750 shares (grant or award)
  2. 4 Grant or award Director acquired 5,750 shares (grant or award)
  3. 4 Open-market sale Chief Executive Officer sold 6,000 shares at $29.06 ($174,360)
  4. 4 Grant or award Director acquired 11,500 shares (grant or award)
  5. 4 Exercise or conversion Chief Operating Officer acquired 5,155 shares (option exercise)
  6. 3/A Insider 3/A
  7. 4 Grant or award Director acquired 5,000 shares (grant or award)
  8. 4 Grant or award Director acquired 5,000 shares (grant or award)
  9. 4 Grant or award Chief Medical Officer acquired 15,000 shares (grant or award)
  10. 4 Grant or award Chief Technology Officer acquired 15,000 shares (grant or award)
  11. 4 Grant or award Director acquired 10,000 shares (grant or award)
  12. 4 Grant or award Chief Executive Officer acquired 50,000 shares (grant or award)
  13. 4 Grant or award Director acquired 5,000 shares (grant or award)
  14. 4 Grant or award Chief Scientific Officer acquired 15,000 shares (grant or award)
  15. 4 Grant or award President and CFO acquired 15,000 shares (grant or award)
  16. 4 Grant or award Director acquired 5,000 shares (grant or award)
  17. 4 Grant or award Chief Business Officer acquired 15,000 shares (grant or award)
  18. 4 Grant or award Director acquired 5,000 shares (grant or award)
  19. 4 Grant or award Chief Operating Officer acquired 15,000 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 9 of 16 · 304 filings